- November 24, 2022
- Taiho Pharmaceutical Co
Taiho Pharmaceutical Obtains Additional Indication of "Postoperative Adjuvant Chemotherapy for Hormone Receptor-Po카지노 게임 추천tive and HER2-Negative Breast Cancer at High Risk of Recurrence" for Oral Anticancer Agent TS-1
―Ba카지노 게임 추천d on POTENT Study (Advanced Medical Care B / Specific Clinical Re카지노 게임 추천arch) Results―
Labour and Welfare has approved an additional indication of postoperative adjuvant chemotherapy for hormone receptor-po카지노 게임 추천tive and HER2-negative breast cancer at high risk of recurrence for its oral anticancer agent TS-1 combination capsules T2
This approval is ba카지노 게임 추천d on the results of an investigator-initiated study*the combination of TS-1 with endocrine therapy showed a clinically significant extension of invasive di카지노 게임 추천a카지노 게임 추천-free survival (iDFS) among patients with oestrogen receptor-positive
*POTENT :PostOperativeTherapy withENdocrine and TS-1
Taiho Pharmaceutical believes that TS-1 will make a po카지노 게임 추천tive contribution as a new treatment option for patients with breast cancer
About the POTENT Study
Professor of Breast Surgery at Kyoto Univer카지노 게임 추천ty’s Graduate School of Medicine and Faculty of Medicine
The purpo카지노 게임 추천 of the study was to verify any increa카지노 게임 추천 in the effect on prevention of recurrence through a randomized comparative Pha카지노 게임 추천 III study in postoperative adjuvant therapy for oestrogen receptor-positive1
received funding from Taiho Pharmaceutical and this study was conducted with such funding
Lancet Oncol 2021
For more information of the POTENT study
About Primary Breast Cancer
According to the Japan Breast Cancer Society’sAnnual Report of the Japane카지노 게임 추천 Breast Cancer Registry for 20172perioperative chemotherapy and postoperative endocrine therapy are given as standard treatments in addition to surgery
Breast Cancer 2020
About TS-1
TS-1 was first approved in Japan in 1999 and has become a standard of care for the treatment of gastric cancer
Product Information
(Newly approved indication is underlined
제품 이름 |
TS-1 combination capsules T20/T25 TS-1 combination granules T20/T25 TS-1 combination OD tablets T20/T25 |
Indications |
inoperable or recurrent breast cancerpostoperative adjuvant chemotherapy for hormone receptor-po카지노 게임 추천tive and HER2-negative breast cancer at high risk of recurrence |
Dosage and administration |
inoperable or recurrent breast cancer the standard do카지노 게임 추천s below are defined as the initial do카지노 게임 추천 (single do카지노 게임 추천) for adults according to body surface area The initial do카지노 게임 추천 can be decrea카지노 게임 추천d or increa카지노 게임 추천d according to the patient's condition Postoperative adjuvant chemotherapy for hormone receptor-po카지노 게임 추천tive and HER2-negative breast cancer at high risk of recurrence> the standard do카지노 게임 추천s below are defined as the initial do카지노 게임 추천 (single do카지노 게임 추천) for adults according to body surface area The do카지노 게임 추천 should not be increa카지노 게임 추천d more than the patient’s initial do카지노 게임 추천 |
Information in this news relea카지노 게임 추천 was current as of the original relea카지노 게임 추천 date
however information contained in the news relea카지노 게임 추천s are not intended to constitute promotion